(Q33340828)

25 July 2017

Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis (English)

1 reference

25 July 2017

1 reference

2

Dick Menzies

1 reference

25 July 2017

3

Kevin Schwartzman

1 reference

25 July 2017

Michael Tan

1

1 reference

PubMed ID

18534007

25 July 2017

language of work or name

English

0 references

publication date

5 June 2008

1 reference

25 July 2017

1 reference

25 July 2017

8

1 reference

25 July 2017

201

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-8-201

25 July 2017

0 references

cites work

False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Causes and costs of hospitalization of tuberculosis patients in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

The cost of tuberculosis: utilization and estimated charges for the diagnosis and treatment of tuberculosis in a public health system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Issues in the management of contacts of patients with active pulmonary tuberculosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

The incidence of false-positive cultures for Mycobacterium tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

School-based screening for tuberculous infection. A cost-benefit analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Health-care expenditures for tuberculosis in the United States.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

The prevalence of tuberculosis and drug resistance among Haitians.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Controlled chemoprophylaxis trials in tuberculosis. A general review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Tuberculosis in a Cohort of Southeast Asian Refugees: A Five-Year Surveillance Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Domestic returns from investment in the control of tuberculosis in other countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Feasibility and reliability of health-related quality of life measurements among tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-8-201

Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

National survey of tuberculosis notifications in England and Wales 1978--9. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2443799

Risk factors for latent tuberculosis infection among children in New York City

31 October 2018

1 reference

12 December 2020

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis

1 reference

12 December 2020

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 reference

12 December 2020

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

1 reference

12 December 2020

Asian immigrant tuberculosis--the effect of visiting Asia

1 reference

12 December 2020

Tuberculin screening: cost-effectiveness analysis of various testing schedules

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-8-201

1 reference

PubMed ID

18534007

Dimensions Publication ID

25 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-8-201

9 September 2019

1 reference

25 July 2017

1 reference

PubMed ID

18534007